Editorial by US Food and Drug Administration Attorney Fails to Address Core and Ongoing Issues Seen With Vasopressin Market

Anesth Analg. 2019 Apr;128(4):e55-e56. doi: 10.1213/ANE.0000000000004042.

¹ Department of Pharmacy Services, University of Kentucky HealthCare, Lexington, Kentucky Department of Pharmacy Practice and Science, University of Kentucky College of Pharmacy, Lexington, Kentucky, philip.almeter@uky.edu Department of Anesthesiology, University of Kentucky College of Medicine, Lexington, Kentucky Department of Pharmacy Services, University of Kentucky HealthCare, Lexington, Kentucky Division of Pulmonary, Critical Care and Sleep Medicine, University of Kentucky College of Medicine, Lexington, Kentucky.

No abstract available

Publication types